Related case:
TJD-AD 2022-009 Disciplinary Decision - Table Tennis
June 14, 2022
Previously the TJD-AD Tribunal had imposed a 4 year period of ineligibility on the table tennis Parathlete after he tested positive for the prohibited substances Androsterone, Etiocholanolone and Testosterone and its metabolites.
Hereafter the Parathlete appealed the Decision with the TJD-AD Appel Panel. The Parathlete admitted the use of Testosterone and denied that the violation was intentional. He acknowledged that he acted negligently and had not mentioned his medication on the Doping Control Form.
He explained that he underwent medical treatment for his diagnosed Hypogonadism. He blaimed his doctor negligence and asserted that he was misinformed about the prescribed medication.
The Rapporteur considers that the table tennis player is an experienced high level Parathlete who had participated in numerous international events. Yet, he failed to mention his medication on the Doping Control Form and he continued using these substances in 2021.
Prior the Athlete failed to apply for a TUE and thereupon his application for a retroactive TUE was denied. Further he only acknowledged the use of the prohibited substance Testosterone whereas the other prescribed substances were inappropriate for the treatment of his Hypogonadism.
Therefore the TJD-AD Appeal Panel decides on 7 December 2022 to dismiss the Athlete's appeal and to uphold the Appealed Decision for the imposition of a 4 year period of ineligibility on the Athlete.